HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshinao Oda Selected Research

ONO-7579

1/2018The Novel Selective Pan-TRK Inhibitor ONO-7579 Exhibits Antitumor Efficacy Against Human Gallbladder Cancer In Vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshinao Oda Research Topics

Disease

338Neoplasms (Cancer)
11/2022 - 01/2002
58Neoplasm Metastasis (Metastasis)
01/2022 - 01/2006
51Carcinoma (Carcinomatosis)
01/2022 - 12/2002
37Adenocarcinoma
03/2022 - 10/2006
32Sarcoma (Soft Tissue Sarcoma)
06/2022 - 10/2003
25Carcinogenesis
07/2022 - 01/2006
25Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2021 - 08/2016
22Stomach Neoplasms (Stomach Cancer)
01/2022 - 10/2006
22Hepatocellular Carcinoma (Hepatoma)
12/2021 - 11/2006
22Pancreatic Neoplasms (Pancreatic Cancer)
06/2021 - 10/2010
19Adenocarcinoma of Lung
11/2021 - 07/2011
18Lung Neoplasms (Lung Cancer)
01/2022 - 07/2016
16Prostatic Neoplasms (Prostate Cancer)
02/2022 - 02/2010
16Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 12/2008
15Synovial Sarcoma (Synovioma)
01/2022 - 04/2002
13Rhabdoid Tumor (Rhabdoid Tumors)
01/2021 - 02/2002
12Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 02/2009
12Breast Neoplasms (Breast Cancer)
01/2022 - 02/2003
12Neoplasms, Cystic, Mucinous, and Serous
07/2018 - 11/2010
10Leiomyosarcoma
07/2022 - 10/2004
10Lymphatic Metastasis
01/2020 - 02/2007
9Infections
01/2022 - 06/2014
9Cholangiocarcinoma
10/2021 - 09/2010
9Neuroendocrine Tumors (Neuroendocrine Tumor)
02/2021 - 01/2014
9Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2020 - 07/2005
8Fibrosis (Cirrhosis)
06/2022 - 04/2016
8Microsatellite Instability
11/2021 - 09/2003
8Esophageal Squamous Cell Carcinoma
08/2021 - 12/2014
8Adenoma (Adenomas)
12/2019 - 10/2010
8Primitive Neuroectodermal Tumors (PNET)
01/2019 - 10/2003
8Neurofibrosarcoma (MPNST)
01/2018 - 05/2005
7Liposarcoma
02/2022 - 09/2002
7Chondrosarcoma
01/2022 - 07/2006
7Melanoma (Melanoma, Malignant)
01/2022 - 08/2004
7Hypoxia (Hypoxemia)
01/2022 - 09/2014
7Osteosarcoma (Osteogenic Sarcoma)
10/2020 - 08/2002
7Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
12/2019 - 01/2002
6Papillomavirus Infections
01/2022 - 01/2013
6Triple Negative Breast Neoplasms
01/2021 - 01/2016
6Neuroendocrine Carcinoma
10/2018 - 04/2015
6Testicular Neoplasms (Testicular Cancer)
01/2018 - 07/2011
6Ewing Sarcoma (Sarcoma, Ewing)
08/2015 - 10/2003
5Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 07/2008

Drug/Important Bio-Agent (IBA)

79Proteins (Proteins, Gene)FDA Link
06/2022 - 02/2003
39Biomarkers (Surrogate Marker)IBA
02/2022 - 05/2005
35Biological ProductsIBA
03/2022 - 08/2002
33LigandsIBA
08/2021 - 07/2002
30B7-H1 AntigenIBA
01/2022 - 01/2015
27Messenger RNA (mRNA)IBA
06/2022 - 01/2002
20ParaffinIBA
11/2022 - 09/2002
18DNA (Deoxyribonucleic Acid)IBA
02/2022 - 04/2002
18Cadherins (E-Cadherin)IBA
01/2022 - 09/2003
17Formaldehyde (Formol)FDA Link
11/2022 - 09/2002
17ErbB Receptors (EGF Receptor)IBA
11/2021 - 05/2005
15Indicators and Reagents (Reagents)IBA
09/2020 - 02/2002
15VimentinIBA
01/2020 - 02/2002
14Small Interfering RNA (siRNA)IBA
01/2019 - 01/2009
12Immune Checkpoint InhibitorsIBA
11/2021 - 07/2017
11AntigensIBA
12/2021 - 06/2014
11Cyclin D1IBA
01/2020 - 01/2002
10Pharmaceutical PreparationsIBA
03/2022 - 01/2006
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2017 - 05/2006
10beta CateninIBA
02/2010 - 01/2002
9Transcription Factors (Transcription Factor)IBA
07/2022 - 11/2004
9Keratins (Keratin)IBA
11/2021 - 02/2002
9AntibodiesIBA
11/2021 - 06/2014
9MucinsIBA
01/2021 - 10/2010
9MicroRNAs (MicroRNA)IBA
07/2019 - 11/2011
8RNA (Ribonucleic Acid)IBA
08/2021 - 01/2019
8Forkhead Transcription Factors (Forkhead Box Proteins)IBA
05/2021 - 09/2015
8CateninsIBA
12/2019 - 01/2011
7CytokinesIBA
01/2022 - 01/2013
7Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2017 - 07/2006
6Mucin-1 (CA 15-3 Antigen)IBA
02/2022 - 08/2004
6alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2022 - 12/2007
6GemcitabineFDA Link
01/2022 - 08/2014
6Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2022 - 01/2018
6Fetal Proteins (Fetoprotein)IBA
12/2021 - 10/2011
6Phosphotransferases (Kinase)IBA
01/2021 - 10/2006
6Androgen Receptors (Androgen Receptor)IBA
01/2021 - 08/2011
6S100 Proteins (S 100 Protein)IBA
01/2021 - 01/2006
6EnzymesIBA
08/2020 - 03/2011
6Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2019 - 10/2012
6Cisplatin (Platino)FDA LinkGeneric
05/2019 - 04/2007
6GlypicansIBA
03/2019 - 10/2012
6Member 1 Subfamily B ATP Binding Cassette TransporterIBA
04/2008 - 02/2003
5Eosine Yellowish-(YS) (Eosin)IBA
07/2022 - 08/2009
5AndrogensIBA
02/2022 - 02/2012

Therapy/Procedure

68Therapeutics
02/2022 - 01/2006
45Drug Therapy (Chemotherapy)
01/2022 - 10/2003
23Immunotherapy
06/2022 - 02/2015
17Radiotherapy
12/2022 - 10/2003
12Pancreatectomy
07/2020 - 10/2010
10Gastrectomy
01/2021 - 09/2012
8Castration
02/2022 - 08/2011
8Adjuvant Chemotherapy
01/2021 - 08/2004
7Lymph Node Excision (Lymph Node Dissection)
01/2022 - 05/2016
7Chemoradiotherapy
11/2021 - 05/2014
7Neoadjuvant Therapy
08/2019 - 12/2015
6Liver Transplantation
12/2021 - 12/2007